Recent News

• 02.11.2026 - Medtronic to announce financial results for its third quarter of fiscal year 2026
• 02.03.2026 - Medtronic advances its innovation strategy with intent to acquire CathWorks
• 02.02.2026 - Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
• 01.23.2026 - Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation
• 01.12.2026 - Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott
• 01.07.2026 - Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus
• 01.05.2026 - Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
• 12.19.2025 - Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
• 12.04.2025 - Medtronic announces cash dividend for third quarter of fiscal year 2026
• 12.03.2025 - Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures

Recent Filings

• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2026 - 3 Initial statement of beneficial ownership of securities
• 01.29.2026 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 12.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.25.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]